News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Dangerous & wrong narrative being promulgated by ISPOR – Richard Sullivan
Photo from womenandcancercommission.org
Jul 11, 2023, 18:24

Dangerous & wrong narrative being promulgated by ISPOR – Richard Sullivan

Dangerous & wrong narrative being promulgated by ISPOR “Continued reliance on .. OS benefit as the primary measure of innovation in oncology ….restrict(s) patient access to innovative therapies & leads to higher healthcare costs”.
For details: Click here
Source: Richard Sullivan/Twitter
cancer Headlines healthcare Innovation ISPOR OncoDaily Oncology Richard Sullivan
Blog
Jul 27, 2024, 12:06
Julie McCrossin: 3 things we can do to improve the physical and emotional recovery of Head and Neck Cancer patients
Blog
Jul 27, 2024, 12:01
Ask the Expert with Amer Zeidan
Blog
Jul 27, 2024, 11:35
Daniel Shapiro: Pleased to present our thoughts on the current adjuvant trials for RCC
Blog
Jul 27, 2024, 11:33
Hamza Hashmi: Looking forward to this ASCO Direct CME event
Positive
Jul 27, 2024, 11:24
Reopening of the Adolescent and Young Adult Lounge at Moffitt Cancer Center
Insight
Jul 27, 2024, 11:23
Anouk Hiensch: Exercise improves quality of life in patients with metastatic breast cancer
Blog
Jul 27, 2024, 11:16
A new episode on Infusion Reactions - Two Onc Docs
Blog
Jul 27, 2024, 11:09
Mark Foundation grantees published 15 papers in top journals In the 2nd quarter of 2024
Blog
Jul 27, 2024, 11:06
KidneyCAN - 2024 Kidney Cancer Patient and Caregiver Education Symposium
Blog
Jul 27, 2024, 11:00
The NCI is seeking qualified candidates to serve as a Supervisory Regulatory and Clinical Operations Specialist - NIH
Blog
Jul 27, 2024, 10:29
Bin Cai: Excellent talks and impressive turnout even on the last day of AAPM2024
Blog
Jul 27, 2024, 10:23
C S Pramesh: Welcome move to exempt some important cancer medicines from customs duty